Bristol-Myers Squibb Company (BMY) Announces Successful Completion of Cash Tender Offer for Shares of Inhibitex, Inc. (INHX)
2/13/2012 6:33:20 AM
More...
|
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Inhibitex, Inc. (INHX), in Connection with the Sale of the Company to Bristol-Myers Squibb Company (BMY)
1/11/2012 6:08:27 AM
More...
|
Bristol-Myers Squibb Company (BMY) to Acquire Inhibitex, Inc. (INHX) for $2.5 Billion
1/9/2012 6:53:43 AM
More...
|
Inhibitex, Inc. (INHX) to Participate in the 2011 Deutsche Bank (DB) BioFEST
12/2/2011 8:41:56 AM
More...
|
Inhibitex, Inc. (INHX) Reports Recent Clinical and Corporate Developments
11/29/2011 9:57:39 AM
More...
|
Inhibitex, Inc. (INHX) to Participate in Four Upcoming Investor Conferences
11/9/2011 8:12:17 AM
More...
|
Inhibitex, Inc. (INHX) Reports Third Quarter Financial Results and Recent Corporate Developments
11/4/2011 7:02:10 AM
More...
|
Inhibitex, Inc. (INHX) to Host Conference Call to Report Third Quarter Financial Results on November 4, 2011
10/27/2011 7:42:46 AM
More...
|
Inhibitex, Inc. (INHX) Commences Dosing of Phase 2 Clinical Trial of INX-189 in HCV Infected Genotype 2/3 Patients
9/19/2011 9:41:19 AM
More...
|
Inhibitex, Inc. (INHX) to Present at Two Upcoming Conferences
8/26/2011 9:43:35 AM
More...
|
|